[APLS] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
30-Jul-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 29.74%
YoY- -66.85%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 94,969 16,322 623 0 0 0 0 -
PBT -121,843 -155,491 -219,191 -118,617 -71,090 -33,334 -12,126 46.87%
Tax 194 486 3,706 6,914 388 -33,669 -12,138 -
NP -122,037 -155,977 -219,191 -118,617 -71,090 -33,334 -12,126 46.91%
Tax Rate - - - - - - - -
Total Cost 217,006 172,299 219,814 118,617 71,090 33,334 12,126 61.69%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -128.50 -955.62 -35,183.15 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -1.02 -1.46 -2.72 -1.57 -1.12 -0.61 -0.67 7.25%
EPS Diluted -1.02 -1.46 -2.72 -1.57 -1.12 -0.61 -0.67 7.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.